Fund It, Build It, Certify It: A MedTech Startup's Roadmap to Market

Most MedTech startups don't stall because the technology fails. They stall because funding and regulation were planned separately.

Under MDR, compliance is not the last step before submission. It shapes your product and company decisions from day one. And investors know it: before a Series A or B, they expect a credible regulatory strategy, not just a promising prototype.

That's why, QbD Group and Capital Cell teamed up, to bring both sides together in one free webinar live session.

"Fund It, Build It, Certify It: A MedTech Startup's Roadmap to Market"
25 November 2026 15:00 CET Online

In 60m you'll learn:

• What investors look for when they assess your regulatory readiness
  • The 8-step roadmap from classification and QMS to CE marking and post-market obligations
  • How to finance your regulatory journey, including grants and public funding
  • Where early decisions make or break your timeline and burn rate
  • How to build for multiple markets from day one (MDR, FDA QMSR, MDSAP)

You can register here: https://hubs.li/Q04DMmsn0